The above studies illustrate that OTUD3 inhibits the malignant progression of breast, glioma, colorectal, cervical, thyroid, and esophageal cancers; conversely, OTUD3 promotes the malignant progression of HCC and lung cancer. Here, OTUD3 is linked to esophageal cancer.